+Search query
-Structure paper
Title | Inhibition of the GAS6/AXL pathway augments the efficacy of chemotherapies. |
---|---|
Journal, issue, pages | J. Clin. Invest., Vol. 127, Page 183-198, Year 2017 |
Publish date | May 24, 2017 (structure data deposition date) |
Authors | Kariolis, M.S. / Miao, Y.R. / Diep, A. / Nash, S.E. / Olcina, M.M. / Jiang, D. / Jones, D.S. / Kapur, S. / Mathews, I.I. / Koong, A.C. ...Kariolis, M.S. / Miao, Y.R. / Diep, A. / Nash, S.E. / Olcina, M.M. / Jiang, D. / Jones, D.S. / Kapur, S. / Mathews, I.I. / Koong, A.C. / Rankin, E.B. / Cochran, J.R. / Giaccia, A.J. |
External links | J. Clin. Invest. / PubMed:27893463 |
Methods | X-ray diffraction |
Resolution | 2.3 Å |
Structure data | PDB-5vxz: |
Chemicals | ChemComp-CA: ChemComp-CL: ChemComp-HOH: |
Source |
|
Keywords | TRANSFERASE / engineered decoy receptor / human cancers |